UNSPSC 41202024: Erysipelothrix rhusiopathiaeserological reagents

In this classification, Erysipelothrix rhusiopathiae serological reagents are devices used in test to identify specific Erysipelothrix rhusiopathiae antibodies in serum. US FDA regulates Erysipelothrix rhusiopathiae serological reagents under 21 CFR 866.3250 and under FDA product code GSD.

UNSPSC 41202024 Erysipelothrix rhusiopathiae serological reagents is a Commodity code, but the recent state and local contract opportunities tagged under it reveal a mismatch between the code's nominal scope and actual purchasing activity. The code nominally describes reagents for detecting Erysipelothrix rhusiopathiae, a bacterium causing swine erysipelas, yet all six recent opportunities posted between May and October 2026 involve HIV testing kits, syphilis reagents, sexually transmitted infection (STI) screening supplies, and general drug testing consumables—work unrelated to the code's stated product line. State and local health departments, criminal justice agencies, and public health programs are the primary issuing bodies, with the Illinois Department of Public Health appearing twice and Collin County, Texas appearing twice across multiple service types (STI testing, offender drug screening, and general lab services). The scope of work being solicited includes rapid diagnostic test kits (Abbott HIV Determine 1/2 tests), Abbott ARCHITECT analyzer reagents and consumables for HIV and syphilis detection, drug testing supplies compatible with drugs-of-abuse analyzers, and integrated laboratory testing services with collection and confirmation protocols.

Opportunities are concentrated in Texas and Illinois. The Illinois Department of Public Health issued two emergency procurements for Abbott HIV/Syphilis reagents in May 2026 and a change order notice in September 2026 for Hologic NG/NT STI testing kits and collection supplies, the latter increasing annual test volume from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units at a cost increase of $375,000 over five years. The City of Austin posted two successive IFBs for rapid HIV test kits in June and August 2026 (IFB 9100 AAM1023 and rebid IFB 9100 AAM1023REBID), each requesting approximately 375 Abbott Determine test kits annually. Collin County issued an RFP in September 2026 for offender specimen collection and drug testing services covering approximately 25,031 annual tests across multiple panel configurations, with an estimated contract value of $600,000 over two years plus three optional one-year renewals. Gwinnett County, Georgia solicited proposals in September 2026 for drug testing supplies compatible with a drugs-of-abuse analyzer, though the solicitation included minimal scope detail. This code shows no relevant recent activity for its stated Erysipelothrix product scope and appears to be a classification error in the state and local procurement system.